The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample
[221+ Pages Report] According to Facts and Factors, the global AI for Drug Discovery Market was valued at about USD 360.01 million in 2020, and is predicted to create revenue of about USD 2,596.6 million by the end of 2026, rising at a CAGR of roughly 39% between 2021 and 2026.
The report covers the forecast and analysis of the AI for the drug discovery market on a global and regional level. The study provides historical data from 2015 to 2018 along with a forecast from 2019 to 2027 based on revenue (USD Million). The study includes drivers and restraints of the AI for the drug discovery market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the AI for drug discovery market on a global level.
In order to give the users of this report a comprehensive view of the AI for drug discovery market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides a company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new service launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.
The study provides a decisive view of the AI for the drug discovery market by segmenting the market based on the drug type, technology, therapeutic area, end-user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2027. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East, and Africa.
With giant pharma firms focusing on genetic data interpretation of patients, the market for AI for drug discovery is likely to gain traction over the forecast timeline. Understanding the patient’s genetic profile assists in providing apt medicines as well as a medical treatment for the patients. Moreover, the computational approaches of machine learning help in analyzing the genetic data of the patient and propose new drugs and therapies.
Based on drug type, the market is sectored into small molecules and large molecules. On the basis of technology, the industry is classified into deep learning, machine learning, and others. In terms of therapeutic area, the market is divided into metabolic diseases, immuno-oncology, neurodegenerative diseases, cardiovascular diseases, oncology, and others. Based on the end-user, the market is segmented into pharmaceutical companies, academic & research institutes, biopharmaceutical companies, and others.
Copyright © 2021, All Rights Reserved, Facts and Factors